Language
English
Publication Date
4-1-2024
Journal
Annals of Clinical and Translational Neurology
DOI
10.1002/acn3.51963
PMID
38504481
PMCID
PMC11021672
PubMedCentral® Posted Date
3-19-2024
PubMedCentral® Full Text Version
Post-print
Abstract
ATP1A1 encodes a sodium-potassium ATPase that has been linked to several neurological diseases. Using exome and genome sequencing, we identified the heterozygous ATP1A1 variant NM_000701.8: c.2707G>A;p.(Gly903Arg) in two unrelated children presenting with delayed motor and speech development and autism. While absent in controls, the variant occurred de novo in one proband and co-segregated in two affected half-siblings, with mosaicism in the healthy mother. Using a specific ouabain resistance assay in mutant transfected HEK cells, we found significantly reduced cell viability. Demonstrating loss of ATPase function, we conclude that this novel variant is pathogenic, expanding the phenotype spectrum of ATP1A1.
Keywords
Child, Humans, Autistic Disorder, Intellectual Disability, Family, Siblings, Adenosine Triphosphatases, Sodium-Potassium-Exchanging ATPase
Published Open-Access
yes
Recommended Citation
Dohrn, Maike F; Bademci, Guney; Rebelo, Adriana P; et al., "Recurrent ATP1A1 Variant Gly903Arg Causes Developmental Delay, Intellectual Disability, and Autism" (2024). Faculty, Staff and Students Publications. 8926.
https://digitalcommons.library.tmc.edu/baylor_docs/8926